References
- Maziere C, Auclair M, Ronveaux M-F, et al. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 1991; 89: 175–82
- Collins P, Rosano GMC, Jiang C, et al. Cardiovascular protection by oestrogen - a calcium antagonist effect?. Lancet 1993; 341: 1264–5
- Mueck A O, Seeger H, Lippert T H. Calcium antagonistic effects of natural and synthetic estrogens. Investigations on a non-genomic mechanism of direct vascular action. Int J Clin Pharm Ther 1996; 34: 424–6
- Heinle H, Orth N, Neeser E, . Effects of 17β-estradiol and its catechol metabolites on the contractility of human uterine artery: in vitro experiments. Sex Steroids and the Cardiovascular System, TH Lippert, AO Mueck, J Ginsburg, et al. Parthenon Publishing, London 1997; 75–83
- Oettel M, Dören M, Hübler D, et al. Freie Radikale und Sexualhormone. J Menopause 1995; 3: 21–8
- Seeger H, Mueck A O, Lippert T H. Comparison of the effect of estradiol with calcium channel blockers – in vitro investigations of calcium influx in human aortic smooth muscle cells. Pharm Pharmacol Lett 1995; 5: 132–4
- Lehmann M, Putz B, Poggel H A, . Experimental toxicity studies with contraceptive steroids and their relevance for human risk estimation. Advances in Applied Toxicology, AD Dayan, AJ Paine, et al. Taylor & Francis, London 1989; 51–79